Statements

15 Oct 2018

DNDi North America submits brief to the Canadian Standing Committee on Health (HESA) Study on Federally Funded Health Research

Statements

10 Sep 2018

DNDi contribution to the World Health Organization roadmap on access to medicines and vaccines 2019-2023

Statements

24 May 2018

DNDi and MMV, supported by Unitaid, deliver statement about R&D and access to child-friendly medicines at the 71st World Health Assembly

Statements

27 Jan 2018

Medicines for Malaria Venture and DNDi deliver statement on R&D for children-friendly medicines at WHO EB142

Statements

21 Sep 2016

DNDi Welcomes the Political Declaration of the United Nations High-Level Meeting on Antimicrobial Resistance

Statements

14 Sep 2016

DNDi response to the Report of the United Nations Secretary-General’s High-Level Panel on Access to Medicines

Statements

27 May 2016

DNDi delivers statement about CEWG on R&D Financing and Coordination at 69th World Health Assembly

Statements

2 May 2016

DNDi Intervention at Open-ended meeting of WHO Member States

Statements

27 Feb 2016

DNDi proposal to UN High-Level Panel on Access to Medicines

Statements

23 Feb 2016

138th session of the WHO Executive Board

Statements

22 May 2015

DNDi statement at 68th World Health Assembly

Statements

11 Jul 2014

Demonstration Financing: Considerations for a Pilot Pooled International Fund for R&D

Statements

11 Dec 2013

G-FINDER Report 2013

Statements

3 Dec 2012

G-FINDER Report 2012

Statements

2 Dec 2011

Call to Action for Latin America to Boost Innovation and Access for Neglected Patients in the Region

Statements

11 Feb 2009

DNDi and Médecins Sans Frontières called for a scale-up of R&D